Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Sarah Grillo/Axios

A seemingly more transmissible coronavirus variant is threatening the world — and exposing the U.S.' lackluster genetic surveillance.

Why it matters: A beefed-up program to sequence the genomes of infectious disease pathogens infections could help the U.S. identify dangerous new coronavirus variants — and get the jump on pathogens that could ignite the pandemics of the future.

Driving the news: New variants of SARS-CoV-2 — including the B.1.1.7 variant that appears to be helping to drive a tremendous spike in infections in the U.K. and Ireland — are being identified by scientists around the world, my Axios colleague Marisa Fernandez reports today.

  • The B.1.1.7 variant is particularly worrying — Public Health England estimates it may be 30–50% more transmissible than other forms of the virus.
  • While a few state health departments in the U.S. have identified a handful of B.1.1.7 cases, the CDC said on Friday that "neither researchers nor analysts at CDC have seen the emergence of a particular variant in the United States."

Yes, but: Genetic surveillance of coronavirus variants in the U.S. lags well behind dozens of other countries, which means we lack a clear picture of exactly how the novel coronavirus currently infecting more than 200,000 people a day is mutating here.

  • To identify whether coronavirus variants are emerging in the U.S., scientists need to genetically sequence infections.
  • But according to the nonprofit GISAID initiative, the U.S. has only sequenced a little more than 60,000 cases since the start of the pandemic, or roughly 0.3% of all cases.
  • That's a little more than half the cases sequenced by the U.K., the world's leader in genetic surveillance, and the median time it takes to post a sequence of the virus on GISAID in the U.S. is 85 days, slower than far poorer countries like Bangladesh and Sri Lanka.

Be smart: The bottleneck here isn't scientific. Genetic sequencing has gotten faster and cheaper, and every state in the U.S. has the technical capacity to decode viral genomes.

  • Rather, the U.S. lacks the kind of unified, national genetic surveillance program adopted by the U.K., which in the spring invested £20 million ($27 million) to launch a scientific consortium that standardized the sequencing and reporting of coronavirus variants.
  • While the CDC in May brought together dozens of labs in an effort to accelerate sequencing, a report by the National Academies of Science, Engineering and Medicine in July concluded current efforts are "typically passive, reactive, uncoordinated, and underfunded."
  • As a result, "currently available data are unrepresentative of many important population features, biased, and inadequate to answer many of the pressing questions about the evolution and transmission of the virus."

What they're saying: "You’ll never find what you aren’t actively looking for," as Michal Tal, a biologist at Stanford University, told the New Republic last month.

  • If the U.S. had a strong national genetic surveillance system in place, it could see evidence of more transmissible variants and amp up vaccination or lockdown procedures before outbreaks got even more out of control.
  • That's precisely what the U.K. government did in December, and in recent days new cases have begun to decline.

What's next: The incoming Biden administration may be open to the idea of a national genetic surveillance program, which would likely cost several hundred million dollars, according to the New York Times.

  • Another option is to accelerate efforts to sequence variant strains from wastewater samples in community sewage systems.
  • A more systematic genetic surveillance program could also pay dividends beyond the COVID-19 pandemic, by helping scientists identify emerging pathogens as soon as possible.

What to watch: If the weak U.S. genetic surveillance system begins to pick up signs that a variant like B.1.1.7 is beginning to dominate cases here, it would indicate a very bad pandemic is about to get much worse.

  • And — since the coronavirus is constantly mutating — entirely new variants could show up, like those identified in Ohio today.

The bottom line: The pandemic has always been a race against time, and without a better genetic surveillance system, the U.S. will be perpetually slow out of the blocks.

Go deeper

Jan 30, 2021 - World

Science helps New Zealand avoid another coronavirus lockdown

New Zealand Prime Minister Jacinda Ardern (L) visits a lab at Auckland University in December. Photo: Phil Walter/Getty Images

New Zealand has avoided locking down for a second time over COVID-19 community cases because of a swift, science-led response.

Why it matters: The Health Ministry said in an email to Axios Friday there's "no evidence of community transmission" despite three people testing positive after leaving managed hotel isolation. That means Kiwis can continue to visit bars, restaurants and events as much of the world remains on lockdown.

Updated 12 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Pfizer coronavirus vaccine safe, effective in children, company says — The COVID booster vaccine discussion is far from over — Cuba becomes first country to begin mass vaccination of children.
  2. Health: Chicago has highest COVID-19 case rates in city worker neighborhoods — International Mission Board to require COVID vaccine for missionaries.
  3. Politics: Biden administration to lift travel ban for fully vaccinated international travelers — Footage shows new details after NYC restaurant incident over proof of vaccination.
  4. Education: More schools using "test-to-stay" strategy to minimize quarantines — Most Kentucky school boards vote in favor of mask mandates —Denver looks to students to close Latino vaccination gap.
  5. Variant tracker: Where different strains are spreading.
Updated 38 mins ago - World

Trudeau's government projected to win Canada election

Canadian Prime Minister Justin Trudeau. Photo: Jeff Vinnick/Getty Images

Canadian Prime Minister Justin Trudeau's Liberal government has been reelected in the national election, the CBC and CTV News projected on Monday night.

By the numbers: The Liberal Party needs to win 170 seats in the 338-seat House of Commons to form a majority government. Preliminary figures show the party ahead with 156 seats at midnight ET, with nearly 66% of polling stations reporting.